Completed
Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
NCT01940172
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
- Locations
-
- TetraLogic research site Fresno, California, United States
- TetraLogic Research Site San Luis Obispo, California, United States
- TetraLogic Research Site Fairway, Kansas, United States
- TetraLogic Research Site Boston, Massachusetts, United States